West Pharmaceutical Services, Inc. (1WST)
MTA
306.80
0.00 (0.00%)
Closed
Aug 21, 2026
Day's Range
306.80306.80
52 wk Range
210.30332.30
Financial Statements - 1WST - West Pharmaceutical Services, Inc.
Revenue
3.07B▲ 26.4%
Net Income
493.70M▲ 19.2%Net Margin 16.1%
EBITDA
822.70M▲ 28.1%
Free Cash Flow
468.90M▲ 101.9%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 3.07B | 2.43B |
| Cost of Goods | 1.97B | 1.59B |
| Gross Profit | 1.10B | 839.06M |
 Operating Expense | - | - |
| Operating Income | 636.10M | 496.55M |
| Non-Operating Interest | - | - |
| Other Income Expense | -52.20M | -18.48M |
| Pre Tax Income | 600.90M | 492.01M |
| Income Tax | 121.60M | 90.33M |
| Net Income | 493.70M | 414.03M |
| EPS Basic | 6.83 | 6.75 |
| EPS Diluted | 6.79 | 6.69 |
| Basic Shares Outstanding | 72.30M | 61.34M |
| Diluted Shares Outstanding | 72.30M | 61.34M |
| Ebit | 601.40M | 494.53M |
| Ebitda | 822.70M | 642.01M |
| Net Income Continuous Operations | 493.70M | 414.03M |
| Minority Interests | - | - |
| Preferred Stock Dividends | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
